期刊文献+

慢性阻塞性肺疾病患者淋巴细胞颗粒溶素的表达及其与血清γ,干扰素、白介素2相关性研究 被引量:3

Expression of granulysin in iymphocytes and correlation analysis with interferon-γ interleukin-2 serum concentrations in chronic obstructive pulmonary disease patients
原文传递
导出
摘要 目的探讨慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)患者不同病期颗粒溶素表达特点以及和γ干扰素(interferon-γ,IFN-γ)、白介素2(interleukin-2,IL-2)之间的关系。方法采用免疫细胞化学技术检测108例COPD患者及46名健康对照组外周血淋巴细胞的表达水平,采用双抗体夹心ABC—ELISA法同步测定血清IFN-γ、IL-2浓度。结果颗粒溶素在COPD患者和健康对照组外周血淋巴细胞中的阳性表达率比较差异有统计学意义(P〈0.01)。颗粒溶素在健康对照组、临床缓解期、急性发作期的外周血淋巴细胞中表达比较差异有统计学意义(P〈0.01)。COPD患者急性发作期血清IFN-γ、1L-2浓度较临床缓解期和健康对照组显著增高(P〈0.01)。COPD患者急性发作期和临床缓解期颗粒溶素表达与血清IFN-γ、IL-2浓度变化均呈正相关,并随着病情变化存在明显消长关系。结论颗粒溶素参与了COPD炎症过程,起着清除病原体的积极作用。IFN-γ、IL-2与颗粒溶素在消除病原体方面可能起着相互协同的作用,可能影响颗粒溶素的释放。 Objective To detect the expression of granulysin in peripheral blood [ymphocytes and its correlation analysis with interferon-γ ( IFN-γ ), interleukin-2 ( IL-2 ) serum concentrations in the immunopathological process of chronic obstructive pulmonary disease(COPD). Methods The expression of granulysin in peripheral blood lymphocytes from 108 patients with COPD and 46 healthy controls was evaluated by means of immunocytocbemieal analysis. Meantime, the concentrations of IFN-T and IL-2 in serum from these patients and healthy controls were also measured by means of double antibody sandwich ABC-ELISA. Results Compared with control subjects,patients with COPD showed an increased expression of granulysin ( P 〈0.01 ). During stables, compared with exacerbations, the expression of granulysin was reduced( P 〈0.01), but compared with controls, it was still higher( P 〈0.01). The serum concentrations of IFN-γ,IL 2 in acute exacerbations were significant higher than those in stables and controls( P 〈0.01). There were positive correlation between the expression of granulysin in acute exacerbations and stables and the change of IFN-γ, IL-2 serum concentration. Conclusions Granulysin may involve in the process of inflammation in COPD by means of eliminating pathogens. There was positive correlation between the expression of granulysin and IFN-γ, IL-2 serum concentration. IFN-γ and IL-2 may play synergetic roles in the process of eliminating pathogen and play a positive cole in the release of granulysin.
出处 《国际呼吸杂志》 2009年第11期658-661,共4页 International Journal of Respiration
关键词 慢性阻塞性肺疾病 颗粒溶素 Γ干扰素 白介素2 Chronic obstructive pulmonary disease Granulysin Interferon-y Interleukin-2
  • 相关文献

参考文献8

二级参考文献45

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2中华医学会老年医学会.中华医学会老年医学会对健康老年人标准的建议(修订草案,1995)[J].中华老年医学杂志,1996,15(1):9-11.
  • 3Zasloff M.Antimicrobial peptides of multicellular organisms[J].Nature,2002,415:389-395.
  • 4Stenger S,Hanson DA,Teitelbaum R,et al.An antimicrobial activity of cytolytic T cells mediated by granulysin[J].Science,1998,282:121-125.
  • 5Sarwal MM,Jani A,Chang S,et al.Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation[J].Hum Immunol,2001,62:21-31.
  • 6Ernst WA,Thoma-Uszynski S,Teitelbaum R,et al.Granulysin,a T cell product,kills bacteria by altering membrane permeability[J].J Immunol,2000,165:7102-7108.
  • 7Deng A,Chen S,Li Q,et al.Granulysin,a cytolytic molecule,is also a chemoattractant and proinflammatory activator[J].J Immunol,2005,174:5243-5248.
  • 8Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Supp1,2003,41:46s-53s.
  • 9Seemunsal TA, Donaldson GC f Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med,2000,161 : 1608-1613.
  • 10Buhl R, Farmer SG. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma.Proc Am Thorac Soc.2004.1:136-142.

共引文献1906

同被引文献15

  • 1国家食品药品监督管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:68.
  • 2国家食品药品监督管理局.中药新药临床研究指导原则(试行).北京:中国医药科技出版社,2002:292-295.
  • 3Calvano S E,Xiao W Z,Richards D R,et al.A network-based analysis of systemic inflammation in humans.Nature,2005,437 (7061):1032-1037.
  • 4Niederman M S,Mandell L A,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163(7):1730-1754.
  • 5Mandell L A,Wunderink R G,Anzueto A,et al.Infectious diseases society of America/American hhoracic society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis,2007,44 (Suppl 2):27-72.
  • 6Wilson C B,Rowell E,Sekimata M.Epigenetic control of T-helper- cell differentiation.Nature Reviews Immunolog,2009,9(2):91-105.
  • 7Mandell LA, Wunderink RG, Anzueto A, et al. Infectious dis- eases society of America/American hhoracic society consensus guidelines on the management of community-acquired pneu- monia in adults [J]. Clin Infect Dis,2007,44 (Suppl 2):27- 72.
  • 8唐阿梅,刘良丽.苗药清肺保元汤治疗难治性肺炎的思路与方法[J].贵阳中医学院学报,2009,31(1):31-35. 被引量:6
  • 9华亚军,刘静,凌厉.TNFα和IL-2在新生儿全身炎症反应综合征中的临床价值[J].上海医药,2009,30(7):323-324. 被引量:5
  • 10胡静,郭永洁.宣白承气汤在肺系疾病急性期治疗中的运用[J].中国中医急症,2009,18(8):1286-1287. 被引量:13

引证文献3

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部